Drugs / SmofKabiven® E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03355079 | Feb 2018 → Apr 2019 | — | Fresenius Kabi | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SmofKabiven E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03355079 ↗ |